ListedSMEHospital & Healthcare ServicesAVIENCE

Avience Biomedicals IPO

Avience Biomedicals IPO is a sme IPO raising ₹30 Cr at ₹196 – ₹208 a share. It listed on 25 Jun 2026 and trades at ₹263 today, +26.2% against its issue price of ₹208. It was subscribed 0.00× in total.

208
Issue price
263
Price now
+26.2%
Since issue price
25 Jun 2026
Listed on
0.00×Subscribed (final) · all exchanges

No bids yet

populated partly populated we hold nothing here — the tab says why

Who bid for it

Investor categoryShares offeredShares bid forSubscribed
QIB
Banks, funds and other large institutions
05,38,37,4000.00×
Foreign Institutional Investorsno separate quota93,85,200n/a
Domestic Financial Institutionsno separate quota67,07,400n/a
Mutual fundsno separate quota8,98,800n/a
Othersno separate quota3,68,46,000n/a
Non-institutional
Wealthy individuals and companies bidding above ₹2 lakh
012,37,08,0000.00×
Non Institutional Investors09,25,66,8000.00×
Corporatesno separate quota11,02,800n/a
Individualsno separate quota9,08,04,600n/a
Othersno separate quota6,59,400n/a
Non Institutional Investors03,11,41,2000.00×
Corporatesno separate quota2,43,600n/a
Individualsno separate quota3,04,91,400n/a
Othersno separate quota4,06,200n/a
Total017,75,45,4000.00×

Sub-categories read no separate quota rather than a dash: the exchange publishes bids at that level but never a reservation against them, so a subscription multiple does not exist — it is not missing data. Bids across both exchanges (NSE and BSE) — the figure usually quoted publicly. Last updated 25 Jul, 05:52 pm IST.

How demand built

Only one reading so far. We sample subscription every hour and store it whenever it moves, so this becomes a curve as bidding runs.